Dr. Priyom Bose

Dr. Priyom Bose

Feature Writer

B.Sc. Botany, M.Sc. Plant Biology and Biotechnology, Ph.D. Plant Biology and Biotechnology

Priyom holds a Ph.D. in Plant Biology and Biotechnology from the University of Madras, India. She is an active researcher and an experienced science writer. Priyom has also co-authored several original research articles that have been published in reputed peer-reviewed journals. She is also an avid reader and an amateur photographer.

Articles from Priyom

New protocol for the study of SARS-CoV-2's medium and long-term outcomes

New protocol for the study of SARS-CoV-2's medium and long-term outcomes

9 Aug 2021
A multi-scale cryo-correlative platform to image SARS-CoV-2 in Vero cells

A multi-scale cryo-correlative platform to image SARS-CoV-2 in Vero cells

9 Aug 2021
Flavonoid-based inhibitors targeting SARS-CoV 3CL protease for the treatment of SARS-CoV-2 infection

Flavonoid-based inhibitors targeting SARS-CoV 3CL protease for the treatment of SARS-CoV-2 infection

9 Aug 2021
New method for producing pseudotyped virus particles bearing spike protein of SARS-CoV-2

New method for producing pseudotyped virus particles bearing spike protein of SARS-CoV-2

5 Aug 2021
Activation of NLRP3 inflammasome by the N protein of SARS-CoV-2 to induce hyperinflammation

Activation of NLRP3 inflammasome by the N protein of SARS-CoV-2 to induce hyperinflammation

5 Aug 2021
A correlation study between time-from-vaccine and SARS-CoV-2 breakthrough infections

A correlation study between time-from-vaccine and SARS-CoV-2 breakthrough infections

5 Aug 2021
Researchers develop nanofibrous filters that can capture and kill airborne coronaviruses under visible light irradiation

Researchers develop nanofibrous filters that can capture and kill airborne coronaviruses under visible light irradiation

4 Aug 2021
Factors affecting SARS-CoV-2 transmission and outbreak control in densely populated areas

Factors affecting SARS-CoV-2 transmission and outbreak control in densely populated areas

3 Aug 2021
Inhibition of SARS-CoV-2 replication in vitro by Losartan

Inhibition of SARS-CoV-2 replication in vitro by Losartan

3 Aug 2021
Nasal version of AstraZeneca SARS-CoV-2 vaccine prevents infection in animal models

Nasal version of AstraZeneca SARS-CoV-2 vaccine prevents infection in animal models

3 Aug 2021

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback